Gloribel Bonilla
Overview
Explore the profile of Gloribel Bonilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pilehvari A, You W, Kimmick G, Camacho F, Bonilla G, Anderson R
Clin Drug Investig
. 2025 Jan;
45(2):59-68.
PMID: 39797932
Background And Objective: Cyclin-dependent kinase (CDK)4/6 inhibitors in combination with endocrine therapy (ET) significantly enhance progression-free survival and overall survival in patients diagnosed with HR+/HER2- metastatic breast cancer (MBC). However,...
2.
Pilehvari A, You W, Kimmick G, Bonilla G, Anderson R
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39762708
Purpose: While previous research has highlighted treatment delay inequities in early-stage breast cancer and identified potential contributing factors, there is limited research on disparities in treatment delays for metastatic breast...
3.
Pilehvari A, Kimmick G, You W, Bonilla G, Anderson R
Breast Cancer Res
. 2024 Oct;
26(1):144.
PMID: 39425174
Objective: This study used real-world observational data to compare profiles of patients receiving different first-line treatment for hormone receptor positive (ER+), HER2 negative, metastatic breast cancer (MBC): CDK4/6 inhibitors (CDK4/6i)...
4.
Fadul C, Sheehan J, Silvestre J, Bonilla G, Bovi J, Ahluwalia M, et al.
Lancet Oncol
. 2024 Aug;
25(9):e432-e440.
PMID: 39214114
The value of interdisciplinary teams in improving outcomes and quality of care of patients with brain metastases remains uncertain, partly due to the lack of consensus on key indicators to...
5.
Kimmick G, Pilehvari A, You W, Bonilla G, Anderson R
Breast Cancer Res Treat
. 2024 Jun;
208(2):263-273.
PMID: 38922546
Purpose: To compare CDK4/6 inhibitor (CDK4/6i) with endocrine therapy (ET) in the first- versus second-line setting for treatment of hormone receptor positive (HR+), HER2 negative, metastatic breast cancer (MBC) using...
6.
Anderson R, Hillemeier M, Camacho F, Harvey J, Bonilla G, Batten G, et al.
J Rural Health
. 2023 Oct;
40(2):282-291.
PMID: 37787554
Purpose: Develop and test a measurement framework of mammogram facility resources, policies, and practices in Appalachia. Methods: Survey items describing 7 domains of imaging facility qualities were developed and tested...
7.
Loughran T, Cohn W, Bonilla G, Anderson R
Cancer Prev Res (Phila)
. 2022 Nov;
15(11):715-720.
PMID: 36317368
Prevention is a cornerstone of the guiding mission of the University of Virginia Comprehensive Cancer Center, which is "to reduce the burden of cancer for the patients of today, through...
8.
Little M, Bonilla G, McMurry T, Pebley K, Klesges R, Talcott G
Eval Health Prof
. 2021 Jul;
45(4):354-361.
PMID: 34308666
Self-generated identification codes (SGICs) are strings of information based on stable participant characteristics. They are often used in longitudinal research to match data between time points while protecting participant anonymity....
9.
Porter K, Krukowski R, Bonilla G, McKenna L, Talcott G, Little M
Mil Med
. 2021 Feb;
187(9-10):e1160-e1168.
PMID: 33637975
Introduction: Military personnel have some of the highest rates of tobacco use in the USA. Within the Air Force, a common point of Airmen's (re-)initiation of tobacco use is during...
10.
Goda T, Mirowska K, Currie J, Kim M, Rao N, Bonilla G, et al.
PLoS Genet
. 2011 Jul;
7(7):e1002167.
PMID: 21750685
Circadian clocks have evolved as internal time keeping mechanisms that allow anticipation of daily environmental changes and organization of a daily program of physiological and behavioral rhythms. To better examine...